Treatment of bacterial infections in the central nervous system and associated neurological disorders in animals

Abstract

The present disclosure relates to methods of control, treatment and / or prevention of a neurological disease or disorder in animals, optionally livestock, comprising administering a therapeutically effective amount of a fluoroquinolone compound, optionally pradofloxacin, or a pharmaceutically acceptable salt, solvate, hydrate or hydrate of salt thereof, wherein the neurological disease or disorder is caused by a bacterial infection in the central nervous system. The present disclosure further provides a method of control, treatment and / or prevention of a bacterial infection in the central nervous system in animals, optionally livestock, comprising administering a therapeutically effective amount of a fluoroquinolone compound, optionally pradofloxacin, or a pharmaceutically acceptable salt, solvate, hydrate or hydrate of salt thereof.

Images